[1] |
MENG Kangkang, LIU Saiyue.
After-marketing safety of coenzyme Q10 for injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 795-798.
|
[2] |
CHEN Chao, ZHU Lan, LIU Lihong, HAN Jiayin, ZHU Yan.
Characteristics of Psoralea corylifolia induced liver injury
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 449-453.
|
[3] |
WEI Anhua, QI Jianjun, WANG Lu, ZENG Lu, GONG Xuepeng, JIANG Ying.
Adverse drug reaction/ event caused by oral antidiabetic drugs
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1415-1420.
|
[4] |
PENG Jing, TUO Yali, LI Qiaoling, ZHOU Rong, LI Xinlin, PENG Hui.
Data analysis of adverse events of clobazam among children based on foreign pharmacovigilance safety spontaneous reporting system
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1264-1268.
|
[5] |
GENG Kexin, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian, SA Rina, JIANG Hao, ZOU Lina.
Safety of traditional Chinese medicine among lactating women and pharmacovigilance
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 908-912.
|
[6] |
SUN Bao, BAI Yanning, ZHANG Yuanyuan, QIAO Yi, YANG Zhifu, WANG Jingwen, WEN Aidong.
Literature review of eosinophilic pneumonia induced by daptomycin
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 757-761.
|
[7] |
WU Yingqi, ZHU Ting, TONG Tong, LI Min, SHEN Aizong.
Factors related to ADR/ADE of albumin bound paclitaxel
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(10): 1123-1127.
|
[8] |
YU Yi, HUANG Qianqian, XIAO Aili.
Analysis of Safety Risks of Ginkgo Biloba Tablets and Other Oral Preparations
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 678-682.
|
[9] |
ZHAO Zeqing, WANG Rui, YU Panpan, QIAO Pingping.
Literature Analysis of Adverse Drug Reactions Induced by Olanzapine
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(3): 260-264.
|
[10] |
YU Yi, WANG Hui, LIU Hongliang, WANG Chunting.
Analysis and Consideration on Risk of Sodium Aescinate for Injection
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(2): 174-177.
|
[11] |
XU Wanyi, CUI Xiangli.
Literature Analysis of 45 Cases of Drug-induced Hyperuricemia
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 574-577.
|
[12] |
LIU Hongming, WANG Jian.
Literature Analysis of 52 Cases of Adverse Drug Reactions Induced by Escitalopram
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 578-582.
|
[13] |
YANG Lei, WANG Fengling, WU Jingwei, LI Jun.
Literature Analysis of Levofloxacin-induced Delirium
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 631-635.
|
[14] |
CAI Jun, LI Huixin, LIU Mengying, YAO Yao, GE Weihong.
Safe Use of Lopinavir/Ritonavir for COVID-19 Based on Literature Analysis of Adverse Reactions
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(6): 326-331.
|
[15] |
WEI Hongtao, SHEN Su, DI Xuan, CUI Can, LIAO Yin, SONG Yao.
Common Adverse Drug Events due to Long-term Medication with Chloroquine / Hydroxychloroquine and Drug Interactions
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(5): 261-266.
|